Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Superantigens: structure-function relationships.

Matthew D Baker1, K Ravi Acharya

  • 1Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath BA2 7AY, UK.

International Journal of Medical Microbiology : IJMM
|May 20, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydroxamate-based inhibitors reveal structural determinants of selectivity for Plasmodium falciparum aminopeptidase P.

The Journal of biological chemistry·2026
Same author

Kinetic and structural characterisation of domain-specific angiotensin I-converting enzyme inhibition by captopril, rentiapril and zofenoprilat.

The FEBS journal·2026
Same author

Correction: Molecular basis of acyl-CoA ester recognition by α-methylacyl-CoA racemase from Mycobacterium tuberculosis.

The Journal of biological chemistry·2025
Same author

Structural basis for inhibition of Mycobacterium tuberculosis α-methylacyl-CoA racemase by 2-arylthiopropanoyl-CoA inhibitor analogs.

The Journal of biological chemistry·2025
Same author

Ciprofloxacin Inhibits Angiotensin I‑Converting Enzyme (ACE) Activity by Binding at the Exosite, Distal to the Catalytic Pocket.

ACS bio & med chem Au·2025
Same author

Molecular basis of domain-specific angiotensin I-converting enzyme inhibition by the antihypertensive drugs enalaprilat, ramiprilat, trandolaprilat, quinaprilat and perindoprilat.

The FEBS journal·2025
Same journal

Successful treatment of rare non-dermatophyte onychomycosis caused by Chaetomium spp. with oral fluconazole and topical terbinafine combination - A case report from Indonesia and literature review.

International journal of medical microbiology : IJMM·2026
Same journal

Toxin gene truncation via IS1132 in non-toxigenic toxin gene-bearing (NTTB) Corynebacterium diphtheriae.

International journal of medical microbiology : IJMM·2026
Same journal

Gain-of-function mutation in the sensor kinase CpxS modulates the antimicrobial resistance and virulence of Pseudomonas aeruginosa.

International journal of medical microbiology : IJMM·2026
Same journal

Mycobacterium tuberculosis identification and antibiotic resistance gene profiling using nanopore sequencing: A new approach for tailoring more effective treatments for patients.

International journal of medical microbiology : IJMM·2026
Same journal

Epidemiology and population structure of Acinetobacter baumannii outbreak in a COVID-19 concentration center.

International journal of medical microbiology : IJMM·2026
Same journal

Herpes simplex virus 1 UL2 protein inhibits RIG-I-like receptor pathway-induced IFN-β activity by disrupting IRF3 activation.

International journal of medical microbiology : IJMM·2026
See all related articles

Superantigens from bacteria like Staphylococcus aureus and Streptococcus pyogenes potently stimulate T-cells by forming a trimolecular complex. This interaction leads to massive cytokine release, causing diseases such as toxic shock syndrome.

Area of Science:

  • Immunology
  • Microbiology
  • Toxicology

Background:

  • Superantigens are potent immuno-stimulatory molecules produced by Staphylococcus aureus and Streptococcus pyogenes.
  • These toxins bridge MHC class II molecules and T-cell receptors, inducing massive T-cell proliferation and cytokine release.
  • This cytokine storm can cause significant host tissue damage, leading to diseases like toxic shock syndrome and scarlet fever.

Purpose of the Study:

  • To summarize the current understanding of superantigen function and structure.
  • To highlight the diverse mechanisms by which superantigens interact with host immune receptors.
  • To underscore the role of superantigens in various infectious diseases.

Main Methods:

  • Review of structural studies on superantigen-receptor interactions.

Related Experiment Videos

  • Integration of findings from genomics initiatives.
  • Analysis of the molecular architecture and binding modes of various superantigens.

    • Main Results:

    • Superantigens form trimolecular complexes with MHC class II and T-cell receptors, causing profound T-cell activation.
    • Massive cytokine release results in epithelial damage, capillary leak, and hypotension.
    • Despite a common molecular architecture, superantigens utilize diverse structural strategies to crosslink immune receptors.

    Conclusions:

    • Superantigens are key virulence factors that manipulate the host immune system to cause disease.
    • Structural and genomic data reveal the complex and varied ways superantigens achieve their potent effects.
    • Understanding these interactions is crucial for developing strategies against superantigen-mediated diseases.